TFS CAPITAL LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$94,000
-20.3%
20,220
-0.6%
0.02%
+4.5%
Q2 2016$118,000
-78.5%
20,352
-77.6%
0.02%
-72.2%
Q1 2016$550,000
+107.5%
90,971
+93.7%
0.08%
+203.8%
Q3 2015$265,000
-43.5%
46,971
+11.0%
0.03%
-43.5%
Q2 2015$469,000
+191.3%
42,311
+300.6%
0.05%
+206.7%
Q4 2014$161,000
-23.0%
10,561
-45.6%
0.02%
-16.7%
Q3 2014$209,000
-91.5%
19,425
-87.9%
0.02%
-90.7%
Q2 2014$2,457,000
+845.0%
160,922
+759.9%
0.19%
+1508.3%
Q4 2013$260,00018,7140.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders